NAMS MENOPAUSE CERTIFICATION EXAM
(CMP) 2026–2027 | COMPLETE STUDY GUIDE
& PRACTICE QUESTIONS WITH EVIDENCE-
BASED ANSWERS & DETAILED RATIONALES
• This 200-question practice exam mirrors the NAMS Menopause Practitioner
Certification (CMP) blueprint — covering physiology, diagnosis, therapeutics, risks,
and special populations with evidence-based EXPERT RATIONALE beneath each
correct answer.
• Work through questions in timed sittings, review every EXPERT RATIONALE
whether you answered correctly or not, and flag items for re-study to maximize
retention before exam day.
1. The hypothalamic-pituitary-ovarian (HPO) axis undergoes significant
changes during the menopausal transition. Which hormone shows the
earliest and most consistent rise during perimenopause?
A. Luteinizing hormone (LH)
B. Estradiol (E2)
C. Follicle-stimulating hormone (FSH)
D. Progesterone
E. Inhibin A
✓ CORRECT ANSWER: C. Follicle-stimulating hormone (FSH)
EXPERT RATIONALE: FSH rises earliest in the menopausal transition due to
declining inhibin B secretion from diminishing ovarian follicles. As follicle numbers
decrease, inhibin B — the primary negative feedback signal on FSH — falls first,
causing FSH to rise before estradiol levels become consistently low. This is why FSH
elevation is the earliest measurable hormonal marker of ovarian aging.
2. A 51-year-old woman presents with her last menstrual period 13 months
ago. She has no bleeding since. By STRAW +10 criteria, she is classified as:
,A. Late perimenopause
B. Early postmenopause (Stage +1a)
C. Late postmenopause (Stage +2)
D. Premature ovarian insufficiency
E. Early perimenopause (Stage −2)
✓ CORRECT ANSWER: B. Early postmenopause (Stage +1a)
EXPERT RATIONALE: STRAW +10 defines menopause as 12 consecutive months of
amenorrhea without other pathological cause. Stage +1a spans the first 12 months
after the final menstrual period (FMP). At 13 months post-FMP, she has just entered
Stage +1b, which covers months 13–24. However per standard classification and
exam context, she is firmly placed in early postmenopause. Stage +2 (late
postmenopause) begins after 5–6 years post-FMP.
3. Which of the following best describes the primary source of estrogen in
postmenopausal women?
A. Ovarian granulosa cells
B. Adrenal cortex direct secretion of estradiol
C. Peripheral aromatization of androgens in adipose tissue
D. Hepatic conversion of estrone to estradiol
E. Pituitary gland secretion under LH stimulation
✓ CORRECT ANSWER: C. Peripheral aromatization of androgens in adipose
tissue
EXPERT RATIONALE: After menopause, ovarian follicular estrogen production
ceases. The dominant source becomes peripheral aromatization of adrenal
androgens — primarily androstenedione — into estrone (E1) in adipose tissue,
muscle, skin, and bone. This is why obesity is associated with higher
postmenopausal estrogen levels and increased endometrial cancer risk.
,4. A 48-year-old woman reports hot flashes, night sweats, and irregular cycles
for 8 months. FSH is 18 IU/L. What is the most appropriate interpretation?
A. FSH confirms surgical menopause
B. FSH level is diagnostic of natural menopause
C. FSH alone is insufficient to confirm menopause during perimenopause
D. FSH excludes premature ovarian insufficiency
E. FSH of 18 indicates normal premenopausal status
✓ CORRECT ANSWER: C. FSH alone is insufficient to confirm menopause during
perimenopause
EXPERT RATIONALE: During perimenopause, FSH levels fluctuate widely and can
vary from normal to menopausal range within a single cycle. A single FSH
measurement is unreliable for confirming menopause in a woman still having
cycles. NAMS guidelines state that menopause diagnosis in women under 45
should include repeated measurements, and that clinical history (12 months
amenorrhea) remains the gold standard in women over 45.
5. What is the NAMS-recommended minimum duration of amenorrhea
required to clinically diagnose natural menopause in a woman aged 50?
A. 3 months
B. 6 months
C. 9 months
D. 12 months
E. 24 months
✓ CORRECT ANSWER: D. 12 months
EXPERT RATIONALE: Natural menopause is defined as 12 consecutive months of
amenorrhea following the final menstrual period, not attributable to any
, pathological cause. This definition, endorsed by NAMS, WHO, and STRAW +10, does
not require laboratory testing in women over 45 with typical symptoms and the
appropriate age range.
6. Genitourinary syndrome of menopause (GSM) encompasses which of the
following symptom clusters?
A. Hot flashes, night sweats, and mood changes
B. Vaginal dryness, dyspareunia, urinary urgency, and recurrent UTIs
C. Cognitive decline, sleep disturbance, and fatigue
D. Decreased libido, depression, and weight gain
E. Osteoporosis, cardiovascular disease, and metabolic syndrome
✓ CORRECT ANSWER: B. Vaginal dryness, dyspareunia, urinary urgency, and
recurrent UTIs
EXPERT RATIONALE: GSM, formerly called vulvovaginal atrophy (VVA), is defined by
NAMS and ISSWSH as a collection of symptoms related to estrogen deficiency
affecting the vulva, vagina, and lower urinary tract. It includes vaginal dryness,
irritation, dyspareunia, urinary urgency, dysuria, and recurrent lower urinary tract
infections. Unlike vasomotor symptoms, GSM is typically progressive and does not
resolve without treatment.
7. Which vaginal pH is most consistent with estrogen-deficient genitourinary
syndrome of menopause?
A. 3.5–4.0
B. 4.0–4.5
C. 4.5–5.0
D. 5.0–6.0
E. Greater than 6.0
(CMP) 2026–2027 | COMPLETE STUDY GUIDE
& PRACTICE QUESTIONS WITH EVIDENCE-
BASED ANSWERS & DETAILED RATIONALES
• This 200-question practice exam mirrors the NAMS Menopause Practitioner
Certification (CMP) blueprint — covering physiology, diagnosis, therapeutics, risks,
and special populations with evidence-based EXPERT RATIONALE beneath each
correct answer.
• Work through questions in timed sittings, review every EXPERT RATIONALE
whether you answered correctly or not, and flag items for re-study to maximize
retention before exam day.
1. The hypothalamic-pituitary-ovarian (HPO) axis undergoes significant
changes during the menopausal transition. Which hormone shows the
earliest and most consistent rise during perimenopause?
A. Luteinizing hormone (LH)
B. Estradiol (E2)
C. Follicle-stimulating hormone (FSH)
D. Progesterone
E. Inhibin A
✓ CORRECT ANSWER: C. Follicle-stimulating hormone (FSH)
EXPERT RATIONALE: FSH rises earliest in the menopausal transition due to
declining inhibin B secretion from diminishing ovarian follicles. As follicle numbers
decrease, inhibin B — the primary negative feedback signal on FSH — falls first,
causing FSH to rise before estradiol levels become consistently low. This is why FSH
elevation is the earliest measurable hormonal marker of ovarian aging.
2. A 51-year-old woman presents with her last menstrual period 13 months
ago. She has no bleeding since. By STRAW +10 criteria, she is classified as:
,A. Late perimenopause
B. Early postmenopause (Stage +1a)
C. Late postmenopause (Stage +2)
D. Premature ovarian insufficiency
E. Early perimenopause (Stage −2)
✓ CORRECT ANSWER: B. Early postmenopause (Stage +1a)
EXPERT RATIONALE: STRAW +10 defines menopause as 12 consecutive months of
amenorrhea without other pathological cause. Stage +1a spans the first 12 months
after the final menstrual period (FMP). At 13 months post-FMP, she has just entered
Stage +1b, which covers months 13–24. However per standard classification and
exam context, she is firmly placed in early postmenopause. Stage +2 (late
postmenopause) begins after 5–6 years post-FMP.
3. Which of the following best describes the primary source of estrogen in
postmenopausal women?
A. Ovarian granulosa cells
B. Adrenal cortex direct secretion of estradiol
C. Peripheral aromatization of androgens in adipose tissue
D. Hepatic conversion of estrone to estradiol
E. Pituitary gland secretion under LH stimulation
✓ CORRECT ANSWER: C. Peripheral aromatization of androgens in adipose
tissue
EXPERT RATIONALE: After menopause, ovarian follicular estrogen production
ceases. The dominant source becomes peripheral aromatization of adrenal
androgens — primarily androstenedione — into estrone (E1) in adipose tissue,
muscle, skin, and bone. This is why obesity is associated with higher
postmenopausal estrogen levels and increased endometrial cancer risk.
,4. A 48-year-old woman reports hot flashes, night sweats, and irregular cycles
for 8 months. FSH is 18 IU/L. What is the most appropriate interpretation?
A. FSH confirms surgical menopause
B. FSH level is diagnostic of natural menopause
C. FSH alone is insufficient to confirm menopause during perimenopause
D. FSH excludes premature ovarian insufficiency
E. FSH of 18 indicates normal premenopausal status
✓ CORRECT ANSWER: C. FSH alone is insufficient to confirm menopause during
perimenopause
EXPERT RATIONALE: During perimenopause, FSH levels fluctuate widely and can
vary from normal to menopausal range within a single cycle. A single FSH
measurement is unreliable for confirming menopause in a woman still having
cycles. NAMS guidelines state that menopause diagnosis in women under 45
should include repeated measurements, and that clinical history (12 months
amenorrhea) remains the gold standard in women over 45.
5. What is the NAMS-recommended minimum duration of amenorrhea
required to clinically diagnose natural menopause in a woman aged 50?
A. 3 months
B. 6 months
C. 9 months
D. 12 months
E. 24 months
✓ CORRECT ANSWER: D. 12 months
EXPERT RATIONALE: Natural menopause is defined as 12 consecutive months of
amenorrhea following the final menstrual period, not attributable to any
, pathological cause. This definition, endorsed by NAMS, WHO, and STRAW +10, does
not require laboratory testing in women over 45 with typical symptoms and the
appropriate age range.
6. Genitourinary syndrome of menopause (GSM) encompasses which of the
following symptom clusters?
A. Hot flashes, night sweats, and mood changes
B. Vaginal dryness, dyspareunia, urinary urgency, and recurrent UTIs
C. Cognitive decline, sleep disturbance, and fatigue
D. Decreased libido, depression, and weight gain
E. Osteoporosis, cardiovascular disease, and metabolic syndrome
✓ CORRECT ANSWER: B. Vaginal dryness, dyspareunia, urinary urgency, and
recurrent UTIs
EXPERT RATIONALE: GSM, formerly called vulvovaginal atrophy (VVA), is defined by
NAMS and ISSWSH as a collection of symptoms related to estrogen deficiency
affecting the vulva, vagina, and lower urinary tract. It includes vaginal dryness,
irritation, dyspareunia, urinary urgency, dysuria, and recurrent lower urinary tract
infections. Unlike vasomotor symptoms, GSM is typically progressive and does not
resolve without treatment.
7. Which vaginal pH is most consistent with estrogen-deficient genitourinary
syndrome of menopause?
A. 3.5–4.0
B. 4.0–4.5
C. 4.5–5.0
D. 5.0–6.0
E. Greater than 6.0
